Valuation (86%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.96 | N/A |
| PEG Ratio (TTM) | 0.91 | N/A |
| P/S Ratio (TTM) | 0.16 | N/A |
| P/B Ratio (TTM) | 0.26 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 1.10 | N/A |
| Price to 5YR AVG FCF Ratio | 1.05 | N/A |
Profitability (20%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | N/A | N/A |
| ROE (TTM) | 3.40% | N/A |
| Net Profit Margin (TTM) | 1.81% | N/A |
| ROIC 5YR AVG | 13.97% | N/A |
Growth (45%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 21.13% | -24.21% | -12.36% |
| Revenue | 3.23% | 9.45% | 3.26% |
| Net Income | 21.09% | -24.19% | -12.36% |
| Cash Flow | N/A | 20.37% | 212.82% |
Health (32%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | N/A | N/A |
| Quick Ratio (TTM) | N/A | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | N/A | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | 1.73 | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |